Dario C Altieri

Title: Celebrating the Innovations of Dario C. Altieri

Introduction

Dario C. Altieri is an esteemed inventor based in Philadelphia, PA, known for his significant contributions to the field of cancer research. With a focus on developing innovative therapeutic treatments, he has garnered three patents that showcase his dedication to advancing medical science and improving patient outcomes.

Latest Patents

Dario's most recent patents include groundbreaking methodologies aimed at detecting and treating tumors that express pT346 PDK1. His first patent details therapeutic treatments specifically targeting gliomas that exhibit this biomarker. The second patent introduces a variant survivin vaccine for the treatment of myeloma. This invention involves a double mutant form of the survivin polypeptide, alongside nucleic acid molecules that encode the survivin variant. These innovations encompass antigen presenting cells, such as dendritic cells, and outline methods for treating malignancies or inducing immune responses.

Career Highlights

Throughout his career, Dario C. Altieri has been associated with notable institutions such as The Wistar Institute of Anatomy & Biology and the H. Lee Moffitt Cancer Center and Research Institute. His work at these renowned organizations has propelled his research into the forefront of cancer therapeutics.

Collaborations

Dario has collaborated with influential professionals in the field, including Frederick L. Locke and Scott Antonia. These partnerships have fostered a collaborative environment, paving the way for innovative solutions in cancer treatment.

Conclusion

Dario C. Altieri exemplifies the spirit of innovation through his patents and collaborative efforts in cancer research. His contributions not only reflect his ingenuity as an inventor but also his commitment to advancing therapeutic options for patients battling malignancies.